Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04291274
Other study ID # SH9H-2019-T293-2
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 1, 2019
Est. completion date December 30, 2019

Study information

Verified date February 2020
Source Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The long-term effect of general anesthesia on developing brain is the focus of clinicians when infants exposed to general anesthesia for a long time during operation. A retrospective study showed that children exposed to long-term or repeated operations, the anesthetics had a higher incidence of cognitive impairment in adolescence than those did no. When infants with hearing impairment undergo bilateral cochlear implant surgery, they are at high risk of long-term neurobehavioral abnormalities caused by anesthesia. In this study, investigators intend to observe the long-term behavioral abnormalities of hearing-impaired infants after intravenous or inhalation anesthesia by a ambispective cohort study.


Description:

Gesell development scale contains five subscales including adaptability, fine motor, gross motor, language, and social skill evaluation. Developmental quotient (DQ) = (development age/actual age)×100. Total DQ is the average of five DQ of subscales. DQ≥86 is normal, 76≤DQ≤85 is suspicious, 55≤DQ≤75 is mild neurological damage, 40≤DQ ≤54 is moderate neurological damage, 25 B DQ B 39 is severe neurological damage, and DQ< 25 is very severe neurological damage.


Recruitment information / eligibility

Status Completed
Enrollment 17
Est. completion date December 30, 2019
Est. primary completion date December 1, 2019
Accepts healthy volunteers
Gender All
Age group 6 Months to 36 Months
Eligibility Inclusion Criteria: - Children undergoing cochlear implantation under general anesthesia - 6 to 36-month-old child - Normal body weight - Children with normal structures of the inner ear and auditory nerve - Children without contraindications to anesthesia and surgery - Patients who have not participated in other clinical trials - Without any acute infectious diseases or systematic diseases Exclusion Criteria: - The participants with a Gesell score (fine motor and gross motor) lower than 86 after preoperative evaluation. - With other illness which could affects curative effect of recovery, such as inner ear malformations (except for large vestibular aqueduct syndrome), auditory vestibular nerve dysplasia, dysgnosia and mental disease; - Inability to cooperate with the hearing evaluation and the language training - Cute and chronic otitis media and mastoiditis, unhealed tympanic membrane perforation - Abnormal structure of brain, including white matter dysplasia, Demyelinating Diseases

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
China Shanghai ninth people's hospital Shanghai
China Shanghai No.9 People's Hospital Shanghai

Sponsors (1)

Lead Sponsor Collaborator
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary change of Baseline Gesell Developmental Scale after 6 month Neurobehavior effects was measured use Gesell Developmental Scale. DQ (Developmental quotient) was calculated by (development age/actual age)×100. Total DQ is the average of five DQ of subscales. DQ=86 is normal, 76=DQ=85 is suspicious, 55=DQ=75 is mild neurological damage, 40=DQ=54 is moderate neurological damage, 25=DQ=39 is severe neurological damage, and DQ <25 is very severe neurological damage change in 6 months after surgery]
See also
  Status Clinical Trial Phase
Recruiting NCT04255485 - The Neurobehavioral Effects of Anesthetics on Infants With Hearing Impairment